HLN 9.69 (-0.1%)
US4055521003Drug ManufacturersDrug Manufacturers - Specialty & Generic

Haleon (HLN) Competitor Comparison

We are evaluating the key criteria listed to compare Haleon (HLN) against its competitors in the Drug Manufacturers - Specialty & Generic industry.

Linearity 5 years - HLN ranking 0 / 54

These are the competitors of Haleon in the industry Drug Manufacturers - Specialty & Generic ranked by linearity 5 years
1. Green Thumb Industries R9U2.F
73.58
2. ProPhase Labs PRPH
32.25
3. Alvotech ALVO
22.34
4. Catalent CTLT
20.24
5. Evolus EOLS
15.4
6. Phibro Animal Health PAHC
13.91
7. Kamada KMDA
12.55
8. Regencell Bioscience Holdings RGC
11.23
9. ANI Pharmaceuticals ANIP
10.42
10. Zoetis ZTS
10.29
11. Neoleukin Therapeutics NLTX
8.58
12. Alimera Sciences ALIM
7.82
13. Organogenesis Holdings ORGO
7.47
14. Vifor Pharma G2AB.F
7.23
15. PetIQ PETQ
6.43
16. Avadel Pharmaceuticals AVDL
5.68
17. Kolinpharma KIP.MI
4.88
18. Pacira BioSciences PCRX
4.6
19. Curaleaf Holdings CURLF
4.43
20. Linc LNC
3.99
21. Perrigo PRGO
3.93
22. Supernus Pharmaceuticals SUPN
3.87
23. Collegium Pharmaceutical COLL
3.72
24. Ayr Wellness 3KJB.F
3.71
25. Taro Pharmaceutical Industries TARO
3.55
26. Elanco Animal Health ELAN
3.42
27. Ironwood Pharmaceuticals IRWD
3.06
28. Cumberland Pharmaceuticals CPIX
2.85
29. Embecta EMBC
2.8
30. Cronos Group CRON
2.75
31. Emergent BioSolutions EBS
2.7
32. Journey Medical DERM
2.69
33. Procaps Group PROC
2.59
34. Theratechnologies THTX
2.53
35. Zynerba Pharmaceuticals ZYNE
2.47
36. Bausch Health Companies BHC
2.39
37. Jupiter Wellness JUPW
2.39
38. Amphastar Pharmaceuticals AMPH
2.24
39. Societal CDMO SCTL
2.21
40. Eagle Pharmaceuticals EGRX
2.19
41. SCYNEXIS SCYX
2.15
42. Relmada Therapeutics RLMD
2.06
43. Amneal Pharmaceuticals AMRX
1.92
44. Alpha Teknova TKNO
1.9
45. Solid Biosciences SLDB
1.9
46. Tilray Brands TLRY
1.89
47. Clever Leaves Holdings CLVR
1.87
48. OptiNose OPTN
1.83
49. Ascend Wellness Holdings AAWH
1.77
50. Biofrontera BFRI
1.74
51. Flora Growth FLGC
1.63
52. Universe Pharmaceuticals UPC
1.61
53. Teva Pharmaceutical Industries TEVA
0.94
54. Harrow Health HROW
0.38

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.